Active investor profile · Sourced from recent funding activity

Kendall Capital Partners

Boston VC backing early-to-commercial life sciences companies in gene therapies, immunotherapies, AI diagnostics, and advanced drug delivery.

Investment Stages

SeedSeries ASeries B

Investment Focus

BioTechHealthTechMedTechAI/MLDeepTech

Founded

2021

Firm Characteristics

Thesis-Driven Early Stage Bio/Health-Focused US-Centric

Looking for more investors like Kendall Capital Partners?

The full list has hundreds of active Seed-stage BioTech investors with offices in Boston — sourced from recent funding rounds, updated July 2026. One-time purchase, instant download.

Download All 11 Investor Lists

CSV + Excel · No subscription · 11 sectors covered

Similar Investors

Investors active at the same stage and sector — all included in the CSV + Excel export.

C&D Emerging Industry Equity Investment

China-based CVC under C&D Group investing in healthcare, advanced manufacturing and TMT startups via direct equity and FOF.

Seed Series A HealthTech BioTech

CDH Investments

China-focused venture and growth capital arm of CDH Investments, backing technology innovators in healthcare, AI, hard tech, and enterprise solutions from early stage through growth.

Seed Series A HealthTech BioTech

R42 Group

Silicon Valley family office VC inventing and investing in deep science startups from pre-seed through growth, focused on AI and longevity biotech.

Pre-Seed Seed AI/ML BioTech

Vi Partners

Swiss VC firm investing in tech and healthcare

Seed Series A HealthTech BioTech

Atma Capital

Investor backing deep science founders in life sciences, digital technology, and sustainability to address universal health and intelligence challenges.

Pre-Seed Seed HealthTech BioTech

Illumina Ventures

Independent VC firm focused on genomics and precision health, backing early-stage companies in life science tools, diagnostics, therapeutics, and sustainability.

Seed Series A BioTech HealthTech

Modi Ventures

Houston-based early-stage VC investing in funds and founders at the intersection of AI and biology.

Pre-Seed Seed BioTech HealthTech

OMX Ventures

Lincolnshire-based early-stage VC investing at the convergence of biology, big data, and AI, backing therapeutics, bio-tools, diagnostics, and synthetic biology companies across North America and Europe.

Seed Series A BioTech HealthTech

Privilege Ventures

FINMA-authorized Swiss early-stage VC backing HealthTech, CleanTech, and AgriFoodTech founders from pre-seed to Series A across Europe.

Pre-Seed Seed HealthTech ClimateTech

Related Investor Lists

Find more Seed-stage BioTech investors

Hundreds of active investors · Filtered by stage, sector & location · Updated July 2026

Download AI Investor List

CSV + Excel · One-time purchase · No subscription

Download AI Investor List